SEC
SlamSEC
SearchBrowseEarnings

Biostax Corp.

Pharmaceutical Preparations·WINTER PARK, FL
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(318 total)

TypeDateAccessionPeriodSize
10-Q
Apr 11, 2025
0001376474-25-000322BIOSTAX CORP - FORM 10-Q SEC FILING
Sep 30, 2024
2.9 MB
25
Feb 20, 2025
0001376474-25-000225FORM 25
—
10.4 KB
8-K
Feb 20, 2025
0001376474-25-000224BIOSTAX CORP. - FORM 8-K SEC FILING
Feb 19, 2025
5.7 MB
10-Q
Aug 19, 2024
0001493152-24-033016
Jun 30, 2024
2.9 MB
10-Q/A
Aug 19, 2024
0001493152-24-033014
Mar 31, 2024
2.9 MB
NT 10-Q
Aug 14, 2024
0001493152-24-031880
Jun 30, 2024
34.8 KB
10-K/A
Jul 5, 2024
0001493152-24-026260
Dec 31, 2023
16.7 MB
10-Q
May 20, 2024
0001493152-24-020636
Mar 31, 2024
2.7 MB
NT 10-Q
May 15, 2024
0001493152-24-019396
Mar 31, 2024
37.4 KB
10-K
Apr 16, 2024
0001493152-24-014710
Dec 31, 2023
17.2 MB
NT 10-K
Apr 1, 2024
0001493152-24-012157
Dec 31, 2023
34.8 KB
8-K
Nov 14, 2023
0001493152-23-041147
Nov 8, 2023
228.3 KB
10-Q
Nov 14, 2023
0001493152-23-040859
Sep 30, 2023
3.0 MB
8-K
Nov 2, 2023
0001493152-23-039083
Oct 24, 2023
225.8 KB
8-K
Oct 24, 2023
0001493152-23-038052
Oct 5, 2023
413.0 KB
8-K
Sep 14, 2023
0001493152-23-032569
Sep 14, 2023
215.5 KB
8-K
Sep 13, 2023
0001493152-23-032514
Sep 13, 2023
3.3 MB
10-Q
Aug 18, 2023
0001493152-23-029368
Jun 30, 2023
3.8 MB
NT 10-Q
Aug 14, 2023
0001493152-23-028109
Jun 30, 2023
35.1 KB
10-Q
May 12, 2023
0001493152-23-016620
Mar 31, 2023
2.7 MB
8-K
Apr 20, 2023
0001493152-23-013035
Apr 20, 2023
15.3 MB
10-K
Apr 10, 2023
0001493152-23-011692
Dec 31, 2022
21.2 MB
NT 10-K
Mar 31, 2023
0001493152-23-010038
Dec 31, 2022
36.6 KB
DEF 14C
Mar 27, 2023
0001493152-23-009136
Mar 27, 2023
337.6 KB
8-K
Mar 6, 2023
0001493152-23-006801
Mar 6, 2023
193.4 KB
25 filings shown
CEO
Griffin Noreen
CFO
Farmer Glen A